Please login to the form below

Not currently logged in
Email:
Password:

Caelyx

This page shows the latest Caelyx news and features for those working in and with pharma, biotech and healthcare.

NICE recommends two drugs for ovarian cancer but rejects three

NICE recommends two drugs for ovarian cancer but rejects three

NICE recommends two drugs for ovarian cancer but rejects three. Paclitaxel and Caelyx given preliminary nod. ... Both paclitaxel and Caelyx (pegylated liposomal doxorubicin hydrochloride) are recommended as monotherapy and also in combination with

Latest news

More from news
Approximately 3 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
90TEN Healthcare

90TEN is an award-winning healthcare communications consultancy that puts people at the heart of everything we do. Our Life.Changing. campaigns...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics